← Back to directory

Bořivoj Vojtěšek

Researcher Next ID · RN-041884

Researcher · Biochemistry, Genetics and Molecular Biology

Czech Academy of Sciences

Prague, Czechia

Accepting doctoral researchersFunding unknown
Works count
503
Citation count
11,642
H-index
55
i10-index
174

Research interests

Biochemistry, Genetics and Molecular Biology
Chemistry
Medicine
Cancer-related Molecular Pathways
Cancer Research and Treatments
Advanced Proteomics Techniques and Applications
Ubiquitin and proteasome pathways
Heat shock proteins research

Publications

  • Radiation-induced astrocyte senescence is rescued by Δ133p53

    Neuro-Oncology · 2019 · 10.1093/neuonc/noz001

  • Radiation-induced astrocyte senescence is rescued by Δ133p53

    Neuro-Oncology · 2019 · 10.1093/neuonc/noz001

  • STAT3, stem cells, cancer stem cells and p63

    Cellular & Molecular Biology Letters · 2018 · 10.1186/s11658-018-0078-0

  • p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration

    Cell Death and Differentiation · 2016 · 10.1038/cdd.2016.37

  • Protein Expression and Purification

    Klinicka onkologie · 2014 · 10.14735/amko20141s92

  • p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes

    Journal of Clinical Investigation · 2013 · 10.1172/jci70355

  • The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.

    RNA Biology · 2012 · https://doi.org/10.4161/rna.20231

  • Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development

    Oncogene · 2012 · 10.1038/onc.2012.346

  • C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances

    Oncogene · 2012 · 10.1038/onc.2012.314

  • Anterior gradient 2: A novel player in tumor cell biology

    Cancer Letters · 2011 · 10.1016/j.canlet.2010.12.023

  • Anterior gradient 2: A novel player in tumor cell biology

    Cancer Letters · 2011 · 10.1016/j.canlet.2010.12.023

  • The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

    Oncogene · 2010 · 10.1038/onc.2010.228

  • The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

    Oncogene · 2010 · 10.1038/onc.2010.228

  • p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence

    Nature Cell Biology · 2009 · https://doi.org/10.1038/ncb1928

  • The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression

    Genes & Development · 2008 · 10.1101/gad.1703008

  • Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin

    Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-07-1422

  • Chaperone-dependent stabilization and degradation of p53 mutants

    Oncogene · 2008 · 10.1038/sj.onc.1211010

  • Small Molecular Weight Variants of p53 Are Expressed in Human Melanoma Cells and Are Induced by the DNA-Damaging Agent Cisplatin

    Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-07-1422

  • Endoplasmic reticulum stress and apoptosis

    Cellular & Molecular Biology Letters · 2006 · 10.2478/s11658-006-0040-4

  • Discriminating functional and non‐functional p53 in human tumours by p53 and MDM2 immunohistochemistry

    The Journal of Pathology · 2005 · 10.1002/path.1838

  • Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141

    Nature Immunology · 2005 · 10.1038/ni1156

  • Discriminating functional and non‐functional p53 in human tumours by p53 and MDM2 immunohistochemistry

    The Journal of Pathology · 2005 · 10.1002/path.1838

  • Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation

    British Journal of Cancer · 1994 · 10.1038/bjc.1994.4

  • Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation

    British Journal of Cancer · 1994 · 10.1038/bjc.1994.4

  • Abnormal expression of wild type p53 protein in normal cells of a cancer family patient

    The Lancet · 1992 · 10.1016/0140-6736(92)92354-i

  • Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli

    Journal of Cell Science · 1992 · https://doi.org/10.1242/jcs.101.1.183

  • An immunochemical analysis of the human nuclear phosphoprotein p53

    Journal of Immunological Methods · 1992 · https://doi.org/10.1016/0022-1759(92)90122-a

  • Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

    PubMed · 1991

  • p53 Protein alterations in human testicular cancer including pre‐invasive intratubular germ‐cell neoplasia

    International Journal of Cancer · 1991 · 10.1002/ijc.2910490209

  • p53 Protein alterations in human testicular cancer including pre‐invasive intratubular germ‐cell neoplasia

    International Journal of Cancer · 1991 · 10.1002/ijc.2910490209

  • Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

    International Journal of Cancer · 1990 · 10.1002/ijc.2910460515

  • Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies

    The Histochemical Journal · 1986 · 10.1007/bf01675198

  • Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies

    The Histochemical Journal · 1986 · 10.1007/bf01675198

Current projects

    No projects listed.